Abstract:Background: Early evaluation and treatment of patients with suspected acute coronary syndrome (ACS) poses a huge challenge to the emergency care system worldwide, but little is known about the contemporary prehospital and emergency department management of these patients. We aimed to investigate the early evaluation, treatment, and outcome of suspected ACS in a representative population of China. Methods: We did a prospective registry study involving a network of 23 emergency departments in China. Each participating site consecutively enrolled adult patients presenting with symptoms suggestive of ACS for at least 12 months between August 2015 and September 2017. All findings were weighted by sampling ratio and variation among EDs in enrollment period. Findings: A total of 13 919 patients were screened. Of those included in the analysis, mean age was 63·8±13·6 years, 57·9% were men. After symptom onset, 40·5% of the patients arrived at emergency department within two hours, and 17·9% were transported by ambulance. Upon arrival to the emergency department, 75·6% had their first ECG completed within ten minutes. Among patients without ST-segment elevation, 10·3% had serial ECGs, 56·6% had serum cardiac biomarkers measured, and 6·4% had serial cardiac biomarkers. Stress test and computed tomography angiography were rarely performed for evaluation. Among patients with ST-segment elevation, 57·3% underwent reperfusion therapy, with 51·3% receiving primary percutaneous coronary intervention and 6·3% receiving fibrinolysis. Post-hoc adjudication showed that over 60% of patients could be attributed to ACS, of which 10·2% received antiplatelet therapy prior to presentation, and by the time of emergency department disposition, 51·1% received antiplatelet therapy. Overall, the emergency department mortality rate was 0·5%, and the 30-day mortality and major adverse cardiac event rates were 3·8% and 6·8%, respectively. Interpretation: The pre-hospital and emergency department evaluation of patients with suspected ACS is insufficient in China. For those with ACS, gaps existed in the early medication and reperfusion therapy as per guidelines. These findings suggest opportunities to improve the quality of early management for suspected ACS and further reduce adverse cardiac events in China. Clinical Trial Registration Details: This study was registered at URL: https://www.clinicaltrials.gov (Unique identifier: NCT02536677). Funding Information: This work was supported by National S&T Fundamental Resources Investigation Project [2018FY100600, 2018FY100602], Shandong Provincial Natural Science Foundation [ZR2017PH070], Taishan Pandeng Scholar Program of Shandong Province [tspd20181220], Taishan Young Scholar Program of Shandong Province [tsqn20161065, tsqn201812129], Key R&D Program of Shandong Province [2020SFXGFY03, 2019GSF108073] and Qilu Young Scholar Program. Declaration of Interests: All authors declare no competing interests. Ethics Approval Statement: The study complies with the Declaration of Helsinki and was approved by the ethical committees of all participating sites. Informed consent was required from each patient to participate in the study.

Thrombolysi and Coronary angiography about patients presented to the ER with chest pain in Beijing

Clinical Analysis of 373 Patients with Non-ST Elevation Acute Coronary Syndrome in a Teaching Hospital

Comparison of the Diagnosis and Management of Patients with Non-ST Elevation Acute Coronary Syndrome Between 2000 and 2006 in a Teaching Hospital

Main Etiologies for Patients Presented to ER with Chest Pain or Chest Pain Equivalent

Corrigendum to "imbalanced Regional Development of Acute Ischemic Stroke Care in Emergency Departments in China"

Emergency Time and Ambulance Used for Patients Presented to ER with Chest Pain or Chest Pain Equivalent

Clinical analysis of acute pulmonary embolism in 49 cases

Trends in Percutaneous Coronary Intervention in China: Analysis of China PCI Registry Data from 2010 to 2018

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Pre-Hospital Care-Seeking in Patients with Acute Myocardial Infarction and Subsequent Quality of Care in Beijing

Current Management of Patients with ST Elevation Myocardial Infarction in Metropolitan Beijing, China.

Emergency Percutaneous Coronary Intervention Treatment of Acute Coronary Syndrome Patients

THE UTILITY RATE OF ELECTIVE PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ST ELEVATION ACUTE MYOCARDIAL INFARCTION IN BEIJING, CHINA

The practical value of emergency coronary angiography in patients with acute cardiac attack of persistent chest pain

PCV85 EFFECT OF CHEST PAIN CENTER ON THE TREATMENT OF PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN TIANJIN, CHINA

Clinical characteristics and in-hospital management strategies in patients with acute coronary syndrome: results from 2,096 accredited Chest Pain Centers in China from 2016 to 2021

Evaluation, Treatment, and Outcomes of Patients with Suspected Acute Coronary Syndrome in the Prehospital and Emergency Department: Findings from a Prospective Multicenter Registry in China

In-hospital Delay to Primary Angioplasty for Patients with ST-elevated Myocardial Infarction Between Cardiac Specialized Hospitals and Non-Specialized Hospitals in Beijing, China.

Percutaneous Coronary Intervention Among Patients With non-ST-segment Elevation Myocardial Infarction and Unstable Angina: Findings From the Improving Care for Cardiovascular Disease in China Project

Invasive Management Strategies And Antithrombotic Treatments In Patients With Non-St-Segment-Elevation Acute Coronary Syndrome In China Findings From The Improving Ccc Project (Care For Cardiovascular Disease In China)

Clinical Analysis of 17 Patients with Pulmonary Embolism in Emergency Department